Guru Ownership Trend
Guru Analysis for iShares Biotechnology ETF (IBB)
iShares Biotechnology ETF (IBB), a key player in the Market sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $80.41 M.
Top institutional holders include Jefferies Group and Joel Greenblatt.
Institutional sentiment is currently Bullish. This is evidenced by a $7.19 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 256.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for iShares Biotechnology ETF (IBB)
Major holders include Jefferies Group ($57.5 M), Joel Greenblatt ($4.47 M), Renaissance Technologies (RenTech) ($4.2 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 379,413 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.19 M, with 5 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited IBB. The total reported sell value was $190.19.
Yes, 1 managers opened new positions in IBB, and 4 increased their existing holdings. The total reported buy value was $7.19 M.
